The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe ...

Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices.

U.S. Medicare price cuts of up to 85% will have a lesser impact on drugmakers than initially feared, with most of the hit ...

By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Novo Nordisk shares rose 5% on Wednesday after analysts said negotiated ...

Urban safety-net hospitals will be in the firing line when sweeping Medicaid funding cuts outlined in the summer’s One Big ...

The federal government’s newly announced savings on 15 expensive prescriptions include the popular Ozempic family of ...

Medicaid cuts are being blamed for the closure of a community health center in New Hampshire’s White Mountains ...

Pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs after months of negotiations, reductions that are expected to produce billions in savings for taxpayers and ...

The Centers for Medicare and Medicaid Services announced that prices for 15 prescription drugs, including Ozempic, would be ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion ...